A Study of LY900014 in Healthy Chinese Participants

Inclusion criteria

• Are overtly healthy native Chinese males or females
• Female participants:

• Women of child-bearing potential who are abstinent or use effective methods of contraception for the entirety of the study.
• Women not of child-bearing potential who are infertile or post-menopausal
• Have a body mass index (BMI) of 18 to 28 kilograms per square meter (kg/m²)
• Are nonsmokers
• Have a fasting plasma glucose value >71 milligrams per deciliter (mg/dL) (3.9 millimoles per liter [mmol/L]) and <108 mg/dL (6.0 mmol/L)

Exclusion criteria

• Are currently enrolled in a clinical study, or have participated, within the last 30 days, in a clinical study involving an investigational product
• Have previously completed or withdrawn from this study or any other study investigating LY900014
• Have known allergies to LY900014 or any components of the formulation
• Have a significant history of cardiovascular, respiratory, hepatic, renal, gastrointestinal, endocrine, hematological, or neurological disorders capable of significantly altering the absorption, metabolism, or elimination of drugs; of constituting a risk when taking the investigational product; or of interfering with the interpretation of data
• Intend to use over-the-counter or prescription medication within 7 and 14 days, respectively, prior to dosing or during the study.
• Have donated blood of more than 400 milliliters (mL) within the previous 6 months of study screening or donated more than 100 mL within the last 30 days.
• Have an average weekly alcohol intake that exceeds 21 units per week (males) and 14 units per week (females)